EPHA1 and benign neoplasm: EPHA1 protein levels showed significant associations with clinicopathological parameters, whereupon patients with an absent EPHA1 immunoreactivity frequently had a lower grade (p<0.001) and absent lymph node metastases (p = 0.015).